Introduction
Severe insulin-resistant diabetes is a characteristic feature of some genetic syndromes that include type A extreme insulin resistance, leprechaunism, Rabson-Mendenhall syndrome, and some forms of lipoatrophic diabetes (1) (2) (3) (4) (5) (6) (7) . The insulin resistance is thought to be caused by primary defects in the insulin receptor as has been shown by studies dealing with cultured fibroblasts and/or EBV-transformed lymphocytes established from the patient's peripheral blood cells. However, there seems to be considerable heterogeneity with respect to the nature of the underlying abnormalities that occur in these syndromes (8) (9) (10) .
From pulse-chase studies of the biosynthesis of the insulin receptor, Hedo et al. have provided evidence for at least two different types of defect (8) . One form is associated with the absence of the receptor and its precursor, which indicates possible defects at the transcriptional or translational level. The other form appears to result from altered posttranslational processing of receptor protein that interferes with its targeting or function. These suppositions have been supported by recent measurements by Northern blot analysis of the amounts of receptor mRNA that appears in transformed lymphocytes, taken from a series of such patients (1 1).
In this report we describe a woman from a consanguineous marriage whose clinical manifestations were compatible with the diagnosis of type A extreme insulin resistance (12) . We have demonstrated that the insulin-receptor precursor is synthesized normally in this patient but has not undergone proteolytic maturation to mature a or , subunits on the cell surface.
MethQds
Patient. The patient was a 23-yr-old Japanese woman who was the product of a marriage between first cousins. She was born after a full-term, uncomplicated delivery; birth weight was 1,750 g. At birth she was noted to have increased body hair. At the age of six, diabetes mellitus was diagnosed, and the patient was noted to have acanthosis nigricans, a disturbance of growth, and impaired intelligence. At the age of 23, the patient was referred to the Kyushu University Hospital. On physical examination she was only 133 cm tall and weighed 36 kg and had acanthosis nigricans on the neck and both axillae, hirsutism, and megadontia accompanied the short stature. The external genitalia were normal. An ultrasonogram revealed bilateral polycystic ovaries. Menses had not yet begun. Brain computed tomography scan showed no abnormality. A glucose tolerance test revealed that plasma glucose levels were 130 mg/dl at fasting and 329 mg/dl at 120 min. The serum insulin concentration was increased from 242 MU/ml at fasting to 1,421 uU/ml at 120 min. An intravenous insulin injection (0.1 U/kg) by bolus showed no significant decrease in plasma glucose. Serum testosterone was 2.9 ng/ml (normal, 0.66-1.95 ng/ml). Neither antiinsulin nor anti-insulin-receptor antibodies were detectable in serum. Insulin binding to erythrocytes was markedly decreased due to the reduction in receptor number. She was the second child and her elder sister had similar clinical manifestations.
Cells. Lymphoblastoid cell lines were established by infecting cells with EBV (4) . Cells were grown in continuous culture in RPMI 1640 medium containing 10% fetal bovine serum. '251-insulin binding to intact cells was measured as described elsewhere (3).
Partial purification ofinsulin receptors. Cultured lymphocytes were solubilized in 50 mM Tris-HCl buffer, pH 7.6, containing 1% Triton X-100 and 1 mM PMSF at 4°C for 60 min. After removing insoluble material by centrifugation, the supernatant was partially purified with wheat germ agglutinin (WGA)'-agarose (13) . '251I-insulin binding to WGA-purified receptors was carried out according to the method of Hedo et al. (14) . Autophosphorylation of WGA-purified receptors was performed by a modification of Grunberger's method (15) . After termination of phosphorylation receptors were immunoprecipitated with an anti-insulin-receptor antibody B (16) obtained from a patient with type B extreme insulin resistance and analyzed by SDS-PAGE in 7.5% resolving gel.
Cell surface iodination. Cell surface proteins were iodinated using Na'25I, glucose oxidase, and lactoperoxidase (17 (Fig. 1 A) . When the insulin receptor was partially purified by WGA-agarose chromatography after solubilizing the cells, insulin binding was also markedly reduced ( Fig. 1 B) . To examine whether this markedly lowered insulin binding might be due to a decrease in the number of insulin receptors on the cell surface, we performed surface labeling using Na1251 and lactoperoxidase, and then immunoprecipitated the receptor with an insulin-receptor autoantibody. As shown in Fig. 2 A, is transported to the surface, which yields the mature a and # subunits on the plasma membrane (18). They also described an additional protein band with an Mr of 210 kD, which was suggested to be a fully glycosylated but uncleaved form of the precursor on the cell surface because this component was labeled by surface iodination and the tryptic fragments of this protein contained peptides from both subunits. The antibody that we used cross-reacted with the 21 0-kD molecule from the patient, so it is unlikely that the antibody would not see the 135-and 95-kD subunits from the patient. In addition, we obtained the same results of surface labeling using another anti-insulin-receptor antibody B-9, which was kindly provided by Dr. C. R. Kahn (data not shown).
To examine the processing of insulin receptors in the patient's cells, biosynthetic labeling by 2-[3H]mannose was carried out (Fig. 2 B) . In normal cells two protein bands with Mr values of 190 and 210 kD, in addition to the a and # subunits, were detected. On the othelr hand, a and f# subunits were not detected in the patient's cells, while the amount of the 1 90-kD precursor was comparable to that of normal cells. Furthermore, the band at Mr = 210 kD was also increased, in agreement with the results of the surface iodination studies. These findings suggested that the precursor protein was not undergoing proteolytic cleavage after its synthesis and that, consequently, the uncleaved form of the receptor was increased. As demonstrated in surface labeling and biosynthetic labeling, the (19) , and (c) a defect in the cellular converting enzyme that catalyzes this proteolytic cleavage event.
